Market revenue in 2023 | USD 160.8 million |
Market revenue in 2030 | USD 261.3 million |
Growth rate | 7.2% (CAGR from 2023 to 2030) |
Largest segment | Contract manufacturing |
Fastest growing segment | Contract Development |
Historical data covered | 2018 - 2022 |
Base year for estimation | 2023 |
Forecast period covered | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Contract Manufacturing, Contract Development |
Key market players worldwide | Eurofins Scientific SE, WuXi Biologics (Cayman) Inc, Catalent Inc, AGC Inc, Siegfried Holding AG, Boehringer Ingelheim, FUJIFILM Holdings Corp, Samsung BioLogics, Rentschler Biopharma SE, Recipharm |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to large molecule drug substance cdmo market will help companies and investors design strategic landscapes.
Contract manufacturing was the largest segment with a revenue share of 66.98% in 2023. Horizon Databook has segmented the Middle East & Africa large molecule drug substance cdmo market based on contract manufacturing, contract development covering the revenue growth of each sub-segment from 2018 to 2030.
Conducting clinical trials in MEA for large molecule drug substance offers advantages such as patient diversity, cost advantage, better infrastructure, and excellent medical facilities.
The only drawback is discrepancies between laws of different countries. Many countries in the region are implementing global standards and collaborating with other global CROs and CDMOs to mark their presence.
These attractive incentive policies have attracted big pharmaceutical companies, such as Pfizer, AstraZeneca, and Amgen in the country. Hence, favorable government policies for clinical trials and increase in adoption of new technologies are factors expected to boost market growth in the region.
Horizon Databook provides a detailed overview of continent-level data and insights on the Middle East & Africa large molecule drug substance cdmo market , including forecasts for subscribers. This continent databook contains high-level insights into Middle East & Africa large molecule drug substance cdmo market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account